Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGAA in Siblings with Pompe Disease
NCT00051935Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2003
- Primary completion
- Apr 2003
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Jan 2003; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00051935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051935.